Genetics of Ataxias in Indian Population: A Collative Insight from a Common Genetic Screening Tool.

印度人群共济失调的遗传学:来自常用基因筛查工具的综合见解

阅读:7
作者:Sharma Pooja, Sonakar Akhilesh Kumar, Tyagi Nishu, Suroliya Varun, Kumar Manish, Kutum Rintu, Asokchandran Vivekananda, Ambawat Sakshi, Shamim Uzma, Anand Avni, Ahmad Ishtaq, Shakya Sunil, Uppili Bharathram, Mathur Aradhana, Parveen Shaista, Jain Shweta, Singh Jyotsna, Seth Malika, Zahra Sana, Joshi Aditi, Goel Divya, Sahni Shweta, Kamai Asangla, Wadhwa Saruchi, Murali Aparna, Saifi Sheeba, Chowdhury Debashish, Pandey Sanjay, Anand Kuljeet Singh, Narasimhan Ranganathan Lakshmi, Laskar Sanghamitra, Kushwaha Suman, Kumar Mukesh, Shaji Cheruvallill Velayudhan, Srivastava Madakasira Vasantha Padma, Srivastava Achal K, Faruq Mohammed
Cerebellar ataxias (CAs) represent a group of autosomal dominant and recessive neurodegenerative disorders affecting cerebellum with or without spinal cord. Overall, CAs have preponderance for tandem nucleotide repeat expansions as an etiological factor (10 TREs explain nearly 30-40% of ataxia cohort globally). The experience of 10 years of common genetic ataxia subtypes for ≈5600 patients' referrals (Pan-India) received at a single center is shared herein. Frequencies (in %, n) of SCA types and FRDA in the sample cohort are observed as follows: SCA12 (8.6%, 490); SCA2 (8.5%, 482); SCA1 (4.8%, 272); SCA3 (2%, 113); SCA7 (0.5%, 28); SCA6 (0.1%, 05); SCA17 (0.1%, 05), and FRDA (2.2%, 127). A significant amount of variability in TRE lengths at each locus is observed, we noted presence of biallelic expansion, co-occurrence of SCA-subtypes, and the presence of premutable normal alleles. The frequency of mutated GAA-FRDA allele in healthy controls is 1/158 (0.63%), thus an expected FRDA prevalence of 1:100 000 persons. The data of this study are relevant not only for clinical decision making but also for guidance in direction of genetic investigations, transancestral comparison of genotypes, and lastly provide insight for policy decision for the consideration of SCAs under rare disease category.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。